From Nasdaq: 2024-05-17 11:46:03

Investors have taken a bullish stance on Moderna, with big trades spotted on publicly available options history. Sentiment is split between 70% bullish and 10% bearish. Notable trades include puts totaling $203,756 and calls totaling $250,820, with price targets set between $50.0 to $190.0. RSI indicators suggest the stock may be overbought.

In the last 30 days, volume and open interest for Moderna options within a strike price range of $50.0 to $190.0 have been monitored. Notable trades include a bullish call sweep expiring on 05/17/24 with a total trade price of $88.8K and a bullish put sweep expiring on 07/19/24 with a total trade price of $54.9K. Educational tips on managing options trading risk are provided.

Moderna, a biotech firm founded in 2010, saw rapid validation of its mRNA technology with the COVID-19 vaccine. With 39 mRNA development candidates in clinical trials, programs span infectious disease, oncology, cardiovascular disease, and rare genetic diseases. MRNA stock volume is 876,007 with a price of $132.5, down -0.14%.

Options trading can offer higher profit potential but comes with greater risk. Serious traders mitigate risk by educating themselves, using multiple indicators, and closely following market movements. For real-time alerts on Moderna options trades, Benzinga Pro is recommended. Earnings for Moderna are expected in 76 days.

Read more at Nasdaq: Check Out What Whales Are Doing With MRNA